QQ客服 官方微博 反馈留言

	Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials
	Zou, Yandun[1,2]; Hu, Chunling[2]; Ye, Wenhui[2]; Fan, Limei[2]; Xu, Likun[1]; Zhang, Aidong[1]
	2015
卷号	136期号:5页码:870
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4290975
专题	暨南大学
作者单位	1.[1]Jinan Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510630, Guangdong, Peoples R China 2.[2]Guangdong Women & Children Hosp, Internal Med, Guangzhou 510630, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zou, Yandun[1,2],Hu, Chunling[2],Ye, Wenhui[2],et al. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials[J],2015,136(5):870.
APA	Zou, Yandun[1,2],Hu, Chunling[2],Ye, Wenhui[2],Fan, Limei[2],Xu, Likun[1],&Zhang, Aidong[1].(2015).Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials.,136(5),870.
MLA	Zou, Yandun[1,2],et al."Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy after drug-eluting stent implantation in coronary arteries: A meta-analysis of randomized controlled trials".136.5(2015):870.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。